|
|
Purpose : Several kinds of exogenous pulmonary surfactants (SF), either synthetic or animalderived,
are being used for the replacement therapy in respiratory distress syndrome (RDS) of
newborn, especially in premature infants, and improved the neonatal mortality and morbidity.
Because synthetic preparations are lack of surfactant protein (SP) and animal-derived
preparations cause immunogenecity of heterogenous SP, there have been great necessity for the
development of next... |
